Pak Fah Yeow International Limited (0239.HK)
HKD 2.27
(-1.3%)
HKD 2.27
(-1.3%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 150.4 Million HKD | 180.03% |
| 2022 | 53.7 Million HKD | 2.89% |
| 2021 | 52.19 Million HKD | 50.99% |
| 2020 | -25.22 Million HKD | -34.56% |
| 2019 | 52.82 Million HKD | 22.4% |
| 2018 | 43.15 Million HKD | -42.37% |
| 2017 | 74.89 Million HKD | -6.43% |
| 2016 | 80.04 Million HKD | -1.51% |
| 2015 | 81.26 Million HKD | 1.99% |
| 2014 | 79.68 Million HKD | 43.16% |
| 2013 | 55.65 Million HKD | -17.93% |
| 2012 | 74.35 Million HKD | 19.23% |
| 2011 | 54.14 Million HKD | -10.7% |
| 2010 | 63.76 Million HKD | -13.02% |
| 2009 | 73.22 Million HKD | 75.33% |
| 2008 | -821.99 Thousand HKD | -20.68% |
| 2007 | 52.64 Million HKD | -5.28% |
| 2006 | 55.58 Million HKD | 27.69% |
| 2005 | 43.53 Million HKD | -22.5% |
| 2004 | 56.17 Million HKD | 34.67% |
| 2003 | 41.71 Million HKD | 55.43% |
| 2002 | 26.83 Million HKD | 169.07% |
| 2001 | 9.97 Million HKD | -70.54% |
| 2000 | 33.86 Million HKD | -9.35% |
| 1999 | 37.35 Million HKD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 80.08 Million HKD | 0.0% |
| 2023 FY | - HKD | 180.03% |
| 2023 Q4 | 77.4 Million HKD | 0.0% |
| 2023 Q2 | 72.99 Million HKD | 0.0% |
| 2022 FY | - HKD | 2.89% |
| 2022 Q2 | 16.62 Million HKD | 0.0% |
| 2022 Q4 | 37.08 Million HKD | 0.0% |
| 2021 Q2 | 20.15 Million HKD | 0.0% |
| 2021 Q4 | 32.04 Million HKD | 0.0% |
| 2021 FY | - HKD | 50.99% |
| 2020 Q4 | 28.81 Million HKD | 0.0% |
| 2020 FY | - HKD | -34.56% |
| 2020 Q2 | 5.76 Million HKD | 0.0% |
| 2019 Q4 | 19.12 Million HKD | 0.0% |
| 2019 FY | - HKD | 22.4% |
| 2019 Q2 | 33.7 Million HKD | 0.0% |
| 2018 FY | - HKD | -42.37% |
| 2018 Q4 | 39.39 Million HKD | 0.0% |
| 2018 Q2 | 3.76 Million HKD | 0.0% |
| 2017 FY | - HKD | -6.43% |
| 2017 Q2 | 31.53 Million HKD | 0.0% |
| 2017 Q4 | 43.35 Million HKD | 0.0% |
| 2016 Q2 | 30.66 Million HKD | 0.0% |
| 2016 Q4 | 49.37 Million HKD | 0.0% |
| 2016 FY | - HKD | -1.51% |
| 2015 Q2 | 42.13 Million HKD | 0.0% |
| 2015 Q4 | 39.13 Million HKD | 0.0% |
| 2015 FY | - HKD | 1.99% |
| 2014 Q4 | 41.92 Million HKD | 0.0% |
| 2014 FY | - HKD | 43.16% |
| 2014 Q2 | 37.75 Million HKD | 0.0% |
| 2013 FY | - HKD | -17.93% |
| 2013 Q4 | 26.81 Million HKD | 0.0% |
| 2013 Q2 | 28.84 Million HKD | 0.0% |
| 2012 Q1 | 18.58 Million HKD | 0.0% |
| 2012 FY | - HKD | 19.23% |
| 2012 Q2 | 18.58 Million HKD | 0.0% |
| 2012 Q4 | 20.73 Million HKD | 11.56% |
| 2012 Q3 | 18.58 Million HKD | 0.0% |
| 2011 Q2 | 13.53 Million HKD | 0.0% |
| 2011 Q4 | 18.58 Million HKD | 37.32% |
| 2011 Q3 | 13.53 Million HKD | 0.0% |
| 2011 Q1 | 13.53 Million HKD | 0.0% |
| 2011 FY | - HKD | -10.7% |
| 2010 Q3 | 15.94 Million HKD | 0.0% |
| 2010 Q2 | 15.94 Million HKD | 0.0% |
| 2010 Q4 | 13.53 Million HKD | -15.08% |
| 2010 FY | - HKD | -13.02% |
| 2010 Q1 | 15.94 Million HKD | 0.0% |
| 2009 Q4 | 15.94 Million HKD | -12.91% |
| 2009 FY | - HKD | 75.33% |
| 2009 Q1 | 18.3 Million HKD | 0.0% |
| 2009 Q2 | 18.3 Million HKD | 0.0% |
| 2009 Q3 | 18.3 Million HKD | 0.0% |
| 2008 Q2 | -1.25 Million HKD | 0.0% |
| 2008 Q3 | -1.25 Million HKD | 0.0% |
| 2008 Q4 | 18.3 Million HKD | 1557.13% |
| 2008 FY | - HKD | -20.68% |
| 2008 Q1 | -1.25 Million HKD | 0.0% |
| 2007 Q3 | 11.81 Million HKD | 0.0% |
| 2007 Q1 | 11.81 Million HKD | 0.0% |
| 2007 FY | - HKD | -5.28% |
| 2007 Q2 | 11.81 Million HKD | 0.0% |
| 2007 Q4 | -1.25 Million HKD | -110.63% |
| 2006 Q3 | 12.76 Million HKD | 0.0% |
| 2006 Q1 | 12.76 Million HKD | 0.0% |
| 2006 Q2 | 12.76 Million HKD | 0.0% |
| 2006 Q4 | 11.81 Million HKD | -7.41% |
| 2006 FY | - HKD | 27.69% |
| 2005 Q4 | 12.76 Million HKD | 28.6% |
| 2005 FY | - HKD | -22.5% |
| 2005 Q3 | 9.92 Million HKD | 0.0% |
| 2005 Q2 | 9.92 Million HKD | 0.0% |
| 2005 Q1 | 9.92 Million HKD | 0.0% |
| 2004 Q1 | 13.26 Million HKD | 0.0% |
| 2004 FY | - HKD | 34.67% |
| 2004 Q4 | 9.92 Million HKD | -25.19% |
| 2004 Q3 | 13.26 Million HKD | 0.0% |
| 2004 Q2 | 13.26 Million HKD | 0.0% |
| 2003 Q4 | 13.26 Million HKD | 35.56% |
| 2003 FY | - HKD | 55.43% |
| 2003 Q1 | 9.78 Million HKD | 0.0% |
| 2003 Q2 | 9.78 Million HKD | 0.0% |
| 2003 Q3 | 9.78 Million HKD | 0.0% |
| 2002 Q3 | 6.08 Million HKD | 0.0% |
| 2002 Q4 | 9.78 Million HKD | 60.78% |
| 2002 Q2 | 6.08 Million HKD | 0.0% |
| 2002 Q1 | 6.08 Million HKD | 0.0% |
| 2002 FY | - HKD | 169.07% |
| 2001 Q4 | 6.08 Million HKD | 242.64% |
| 2001 Q3 | 1.77 Million HKD | 0.0% |
| 2001 Q2 | 1.77 Million HKD | 0.0% |
| 2001 FY | - HKD | -70.54% |
| 2001 Q1 | 1.77 Million HKD | 0.0% |
| 2000 Q1 | 7.54 Million HKD | 0.0% |
| 2000 Q4 | 1.77 Million HKD | -76.45% |
| 2000 Q3 | 7.54 Million HKD | 0.0% |
| 2000 Q2 | 7.54 Million HKD | 0.0% |
| 2000 FY | - HKD | -9.35% |
| 1999 FY | - HKD | 0.0% |
| 1999 Q2 | 8.69 Million HKD | 0.0% |
| 1999 Q1 | 8.69 Million HKD | 0.0% |
| 1999 Q4 | 7.54 Million HKD | -13.21% |
| 1999 Q3 | 8.69 Million HKD | 0.0% |
| 1998 Q4 | 8.69 Million HKD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Grand Pharmaceutical Group Limited | 2.96 Billion HKD | 94.93% |
| Extrawell Pharmaceutical Holdings Limited | -129.51 Million HKD | 216.121% |
| Wai Yuen Tong Medicine Holdings Limited | 113.79 Million HKD | -32.164% |
| Qianhai Health Holdings Limited | -50.22 Million HKD | 399.429% |
| Lee's Pharmaceutical Holdings Limited | 109.82 Million HKD | -36.951% |
| Essex Bio-Technology Limited | 418.37 Million HKD | 64.052% |
| Tongfang Kontafarma Holdings Limited | 76.63 Million HKD | -96.26% |
| PuraPharm Corporation Limited | -26.16 Million HKD | 674.726% |
| SSY Group Limited | 2.11 Billion HKD | 92.887% |
| JBM (Healthcare) Limited | 204.39 Million HKD | 26.415% |
| Jacobson Pharma Corporation Limited | 429.92 Million HKD | 65.017% |
| China Resources Pharmaceutical Group Limited | 15.43 Billion HKD | 99.025% |